OnabotulinumtoxinA

Details

Files
Generic Name:
OnabotulinumtoxinA
Project Status:
Complete
Therapeutic Area:
Neurogenic detrusor overactivity
Manufacturer:
Allergan Inc.
Call for patient/clinician input open:
Brand Name:
Botox
Project Line:
Reimbursement Review
Project Number:
SR0268-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Neurogenic Detrusor Overactivity
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: